Table 2 Main features of patients with chronic inflammatory rheumatic diseases (CIRDs) (n=22)

Male/Female (n)

7/15

Age (years; median/range)

53/36-79

Diagnosis: PsA/RA/AS

11/8/3

Symptoms onset (months ago; median/range)

75/24-420

CRP (mg/dl; median/25^th-75^th percentile)

0.09/0-1.225

ESR (mm/h; median/25^th-75^th percentile)

18.5/13.25-33.75

HAQ (0-3; mean/SD)

1.275 ± 0.82

DAS28-ESR (mean/SD)*

4.6 ± 1

DAS28-CRP (mean/SD)*

4.05 ± 0.99

Physician’s global assessment of disease activity (0-100 mm, VAS; mean/SD)*

56.3 ± 28.2

Patient’s global assessment of disease activity

(0-100 mm, VAS; mean/SD)*

59.6 ± 30.5

BASDAI (1-10; mean/SD)**

7.1 ± 3

Concomitant DMARDs (n/%)

10/45.4

Concomitant DMARDs and glucocorticoids (n/%)

4/18.2

Concomitant glucocorticoids (n/%)

10/45.4

No concomitant treatment (n/%)

6/27.3